Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ijantimicag.2010.10.011PMID 21130608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Staphylococcus aureus host cell invasion and post-invasion events.

  2010cited by this paper
• Liposomes as delivery systems for antibiotics.

  2010cited by this paper
• Recent changes in vancomycin use in renal failure.

  2010cited by this paper
• Staphylococcus aureus: new evidence for intracellular persistence.

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

  2009cited by this paper
• O32 Pharmacokinetic evaluation of novel liposomal formulations of vancomycin

  2009cited by this paper
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

  2008cited by this paper
• Pneumonia caused by methicillin-resistant Staphylococcus aureus.

  2008cited by this paper
• Delivery systems to increase the selectivity of antibiotics in phagocytic cells.

  2008cited by this paper
• Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.

  2008cited by this paper
• High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

  2006cited by this paper
• The pharmacokinetic and pharmacodynamic properties of vancomycin.

  2006cited by this paper
• Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.

  2006cited by this paper
• Immune evasion by staphylococci

  2005cited by this paper
• Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States

  2005cited by this paper
• Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

  2004cited by this paper
• Treatment of experimental osteomyelitis by liposomal antibiotics.

  2004cited by this paper
• Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form

  2001cited by this paper
• Is Staphylococcus aureus an intracellular pathogen?

  2000cited by this paper
• Penetration of vancomycin into human lung tissue.

  1996cited by this paper
• Delivery of antimicrobials to infected tissue macrophages

  1995cited by this paper
• Enhanced killing of methicillin-resistantStaphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin

  1994cited by this paper
• Mechanism of vancomycin transport in the kidney: studies in rabbit renal brush border and basolateral membrane vesicles.

  1991cited by this paper
• Intraphagocytic penetration of antibiotics.

  1988cited by this paper

• Nanomedicine applications for the treatment of Staphylococcus aureus infections

  2026cites this paper
• Eradicating extra- and intra-cellular Staphylococcus aureus and MRSA with little accumulation of resistance by a cationic BODIPY derivative.

  2025cites this paper
• Nanomaterial-Based Drug Delivery Systems in Overcoming Bacterial Resistance: Current Review.

  2025cites this paper
• Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections

  2025cites this paper
• Bacteria-Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy.

  2025cites this paper
• Nanoscaled Drug Delivery Carriers for the Targeted Delivery of Vancomycin: Overcoming Bacterial Resistance through Advanced Formulation Strategies

  2025cites this paper
• Nanobiotics to tackle efflux-mediated resistance in bacterial pathogens.

  2025cites this paper
• Efficacy of Gentamicin-Loaded Chitosan Nanoparticles Against Staphylococcus aureus Internalized in Osteoblasts

  2024cites this paper
• Production and optimization of lipid-based “stealth nanocarriers” by supercritical technology

  2024cites this paper
• Shock wave assisted intracellular delivery of antibiotics against bone infection with Staphylococcus aureus via P2X7 receptors

  2024cites this paper
• Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat Study

  2023cites this paper
• Influence of Lipid Composition on Physicochemical and Antibacterial Properties of Vancomycin-Loaded Nanoscale Liposomes

  2023cites this paper
• Antimicrobial-loaded biodegradable nanoemulsions for efficient clearance of intracellular pathogens in bacterial peritonitis.

  2023cites this paper
• Advances in Diagnostic Approaches and Therapeutic Management in Bovine Mastitis

  2023cites this paper
• Preparation of multivesicular liposomes for the loco-regional delivery of Vancomycin hydrochloride using active loading method: drug release and antimicrobial properties

  2023cites this paper
• Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus.

  2023cites this paper
• Nanomaterials: The New Antimicrobial Magic Bullet.

  2022cites this paper
• Expanding therapeutic strategies for intracellular bacterial infections through conjugates of apoptotic body-antimicrobial peptides.

  2022cites this paper
• A Highly Efficacious Electrical Biofilm Treatment System for Combating Chronic Wound Bacterial Infections

  2022cites this paper
• Daptomycin Cross-Linked Chitosan Nanoparticles Serve as an Antibacterial Drug Delivery System

  2022cites this paper
• Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis

  2022cites this paper
• In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes

  2022cites this paper
• Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections

  2022cites this paper
• Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance

  2021cites this paper
• Surface-engineered liposomes for dual-drug delivery targeting strategy against methicillin-resistant Staphylococcus aureus (MRSA)

  2021cites this paper
• Pharmacoengineering of Lipid Nanoarchitectonics in Modulating Particle Uptake by Lung Macrophages

  2021cites this paper
• Compartmentalized Polymeric Nanoparticles Deliver Vancomycin in a pH-Responsive Manner

  2021cites this paper
• Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus

  2021cites this paper
• Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections.

  2021cites this paper
• An AIEgen as an Intrinsic Antibacterial Agent for Light‐Up Detection and Inactivation of Intracellular Gram‐Positive Bacteria

  2021cites this paper
• Development of Vancomycin Delivery Systems Based on Autologous 3D Platelet-Rich Fibrin Matrices for Bone Tissue Engineering

  2021cites this paper
• Liposomal delivery systems and their applications against Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.

  2021cites this paper
• Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA).

  2021cites this paper
• Nanobiosystems for Antimicrobial Drug-Resistant Infections

  2021cites this paper
• Assessment of the Antibacterial Potential of Biosynthesized Silver Nanoparticles Combined with Vancomycin Against Methicillin-Resistant Staphylococcus aureus–Induced Infection in Rats

  2021cites this paper
• Is intracellular Staphylococcus aureus associated with recurrent infection in a rat model of open fracture?

  2020cites this paper
• Nanoparticles for treatment of bovine Staphylococcus aureus mastitis

  2020influential citation
• Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance

  2020cites this paper
• Reconstructed Apoptotic Bodies as Targeted 'Nano Decoys' to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.

  2020cites this paper
• Evasion of host defenses by intracellular Staphylococcus aureus.

  2020cites this paper
• Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions

  2020cites this paper
• Nanoparticulate Antibiotic Systems as Antibacterial Agents and Antibiotic Delivery Platforms to Fight Infections

  2020cites this paper
• Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: using nanoparticles to overcome multidrug resistance.

  2020cites this paper
• Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus.

  2020cites this paper
• Nanobioconjugates: Weapons against Antibacterial Resistance.

  2020cites this paper
• Gut Check Time: Antibiotic Delivery Strategies to Reduce Antimicrobial Resistance.

  2019cites this paper
• The bactericidal effect of liposomal vancomycin as a topical combating system against Methicillin-resistant Staphylococcus aureus skin wound infection in mice

  2019cites this paper
• Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections.

  2019cites this paper
• Anti–Methicillin-Resistant Staphylococcus aureus Nanoantibiotics

  2019cites this paper
• Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm

  2019cites this paper
• Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying

  2018cites this paper
• Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus

  2018cites this paper
• Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

  2018cites this paper
• Glyconanoparticles for targeting macrophages to deliver therapeutic agents

  2018cites this paper
• Factors pivotal for designing of nanoantimicrobials: an exposition

  2018cites this paper
• Nanodelivery strategies for the treatment of multidrug‐resistant bacterial infections

  2018cites this paper
• Pterostilbene, a Methoxylated Resveratrol Derivative, Efficiently Eradicates Planktonic, Biofilm, and Intracellular MRSA by Topical Application

  2017cites this paper
• Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook

  2017cites this paper
• Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance.

  2017cites this paper
• Chapter 21 – Fats

  2017cites this paper
• Particle engineering for intracellular delivery of vancomycin to methicillin‐resistant Staphylococcus aureus (MRSA)‐infected macrophages

  2017cites this paper
• Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria.

  2017cites this paper
• Nanoparticle-based local antimicrobial drug delivery.

  2017cites this paper
• Advancements on the molecular design of nanoantibiotics: current level of development and future challenges

  2017cites this paper
• Drug delivery to macrophages: Challenges and opportunities.

  2016cites this paper
• Effect of neonatal malnutrition on expression of nitric oxide synthase enzyme, production of free radicals and in vitro viability of alveolar macrophages infected with methicillin-sensitive and methicillin-resistant Staphylococcus aureus

  2016cites this paper
• TRIGGERED RELEASE OF VANCOMYCIN TO BACTERIAL INFECTION SITES USING pH-SENSITIVE LIPID BASED NANOPARTICLES

  2016cites this paper
• Polyelectrolyte complex of vancomycin as a nanoantibiotic: Preparation, in vitro and in silico studies.

  2016cites this paper
• Liposomes for systematic delivery of vancomycin hydrochloride to decrease nephrotoxicity: Characterization and evaluation

  2015cites this paper
• Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection

  2015cites this paper
• Silver salts of carboxylic acid terminated generation 1 poly (propyl ether imine) (PETIM) dendron and dendrimers as antimicrobial agents against S. aureus and MRSA

  2015cites this paper
• Liposomal β-Glucan: Preparation, Characterization and Anticancer Activities

  2015cites this paper
• Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems.

  2015cites this paper
• Long-term effects of neonatal malnutrition on microbicide response, production of cytokines, and survival of macrophages infected by Staphylococcus aureus sensitive/resistant to methicillin

  2014cites this paper
• Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.

  2014cites this paper
• Biodegradable nanoparticles for intracellular delivery of antimicrobial agents.

  2014influential citation
• Novel Formulations for Antimicrobial Peptides

  2014influential citation
• Liposomal Clarithromycin: Effectiveness, Safety and Modulation of Pseudomonas

  2013cites this paper
• Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors

  2013cites this paper
• Immunological parameters of macrophages infected by methicillin resistant/sensitive Staphylococcus aureus

  2013cites this paper
• Liposomal clarithromycin delivery for the treatment of pseudomonal lung infection in cystic fibrosis.

  2013cites this paper
• Development and Validation of a Rapid High-Performance Liquid Chromatography Method with UV Detection for the Determination ofVancomycin in Mouse Plasma

  2012cites this paper
• Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model.

  2012cites this paper
• Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus.

  2012cites this paper
• In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against Pseudomonas aeruginosa (ATCC 29248)

  2012influential citation
• Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery.

  2012cites this paper
• Development and Stability Studies of Novel Liposomal Vancomycin Formulations

  2012cites this paper
• Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics

  2011cites this paper
• PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin

  2011influential citation
• Autologu fibrīna matricu izstrāde medicīniskam pielietojumam

  year unknowncites this paper
• Br Ief Definitive Repor T Identification and Treatment of the Staphylococcus Aureus Reservoir in Vivo

  year unknowncites this paper
• Development of Autologous Fibrin Matrices for Medical Application

  year unknowncites this paper